First Time Loading...

ATAI Life Sciences NV
NASDAQ:ATAI

Watchlist Manager
ATAI Life Sciences NV Logo
ATAI Life Sciences NV
NASDAQ:ATAI
Watchlist
Price: 1.91 USD -1.55% Market Closed
Updated: May 15, 2024
ATAI
/
Income Statement
/
Revenue

ATAI Life Sciences NV
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ATAI Life Sciences NV
Revenue Peer Comparison

Comparables:
BAYN
MRK
93M1
DMP
PSG

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
ATAI Life Sciences NV
NASDAQ:ATAI
Revenue
$314k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bayer AG
XETRA:BAYN
Revenue
€47.6B
CAGR 3-Years
5%
CAGR 5-Years
5%
CAGR 10-Years
2%
Merck KGaA
XETRA:MRK
Revenue
€21B
CAGR 3-Years
6%
CAGR 5-Years
7%
CAGR 10-Years
7%
MPH Health Care AG
XETRA:93M1
Revenue
€37.4k
CAGR 3-Years
-5%
CAGR 5-Years
-39%
CAGR 10-Years
N/A
Dermapharm Holding SE
XETRA:DMP
Revenue
€1.1B
CAGR 3-Years
13%
CAGR 5-Years
15%
CAGR 10-Years
N/A
PharmaSGP Holding SE
XETRA:PSG
Revenue
€85.8m
CAGR 3-Years
11%
CAGR 5-Years
10%
CAGR 10-Years
N/A

ATAI Life Sciences NV
Revenue Breakdown

Breakdown by Geography
ATAI Life Sciences NV

Not Available

Breakdown by Segments
ATAI Life Sciences NV

Total Revenue: 314k USD
100%
Research And Development Services: 300k USD
95.5%

See Also

What is ATAI Life Sciences NV's Revenue?
Revenue
314k USD

Based on the financial report for Dec 31, 2023, ATAI Life Sciences NV's Revenue amounts to 314k USD.

What is ATAI Life Sciences NV's Revenue growth rate?
Revenue CAGR 1Y
37%

Over the last year, the Revenue growth was 37%.

ALPHA SPREAD
Join more than 137,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.